Kieran Durkin
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kieran Durkin.
Bioorganic & Medicinal Chemistry Letters | 1999
Satoru Kuroda; Atsushi Akahane; Hiromichi Itani; Shintaro Nishimura; Kieran Durkin; Takayoshi Kinoshita; Yoshiyuki Tenda; Kazuo Sakane
Novel 3-(2-cycloalkyl and cycloalkenyl-3-oxo-2,3-dihydropyridazin-6-yl)-2-phenylpyrazo lo [1,5-a]-pyridines were synthesized and evaluated for their adenosine A1 receptor binding activities. In this series, FR166124 (3) was found to be the most potent and selective adenosine A1 receptor antagonist, and the double bond of the cyclohexenyl acetic acid group was essential for selectivity of A1 receptor binding. Furthermore, the solubility in water of the sodium salt of FR 166124 was high.
Bioorganic & Medicinal Chemistry Letters | 2011
Michael Soth; Sarah C. Abbot; Allassan Abubakari; Nidhi Arora; Humberto Bartolome Arzeno; Roland Joseph Billedeau; Nolan James Dewdney; Kieran Durkin; Sandra Frauchiger; Manjiri Ghate; David Michael Goldstein; Ronald J. Hill; Andreas Kuglstatter; Fujun Li; Brad Loe; Kristen Lynn Mccaleb; Joel McIntosh; Eva Papp; Jaehyeon Park; Martin Stahl; Man-Ling Sung; Rebecca T. Suttman; David C. Swinney; Paul Weller; Brian Wong; Hasim Zecic; Tobias Gabriel
Learnings from previous Roche p38-selective inhibitors were applied to a new fragment hit, which was optimized to a potent, exquisitely selective preclinical lead with a good pharmacokinetic profile.
Bioorganic & Medicinal Chemistry | 2000
Satoru Kuroda; Atsushi Akahane; Hiromichi Itani; Shintaro Nishimura; Kieran Durkin; Yoshiyuki Tenda; Kazuo Sakane
A novel series of 3-(2-cyclohexenyl-3-oxo-2,3-dihydropyridazin-6-yl)-2-phenylpyrazol o[1,5-a]pyridines was synthesized and evaluated for in vitro adenosine A1 and A2A receptor binding activities. Most of the cyclohexenyl derivatives (7a-e, 8a-s) were found to be potent adenosine A1 receptor antagonists. In a series of analogues of FR166124 (3a), alcohol 7c, nitrile 7e and amide derivatives (7d, 8c, 8r) were found to be more potent A1 antagonists with higher A2A/A1 selectivity than FR166124. Amongst them, 8r showed considerable water solubility (33.3 mg/mL), but lower than that of the sodium salt of FR166124 (> 200 mg/mL). Additionally, FR166124 had strong diuretic activity by both p.o. and iv administration in rats (minimum effective dose=0.1 and 0.032 mg/kg, respectively).
Tetrahedron | 1999
Satoru Kuroda; Atsushi Akahane; Hiromichi Itani; Shintaro Nishimura; Kieran Durkin; Takayoshi Kinoshita; Isao Nakanishi; Kazuo Sakane
Abstract An efficient synthesis of FR166124 ( 1 ) was achieved through a novel sequential Horner-Emmons -isomerization reaction of cyclohexanone ( 2 ) with tert -butyl diethylphosphonoacetate ( 3 ) as the key process. Extensive studies of the key reaction indicated that temperature, base and conformation of the Horner-Emmons products were important factors in the isomerization reaction, leading to a proposed mechanism for this unusual Horner-Emmons reaction.
Archive | 2004
Terrence Joseph Connolly; Kieran Durkin; Keshab Sarma; Jiang Zhu
Archive | 2006
Nidhi Arora; Humberto Bartolome Arzeno; Roland Joseph Billedeau; Nolan James Dewdney; Kieran Durkin; Tobias Gabriel; Kristen Lynn Mccaleb; Michael Soth; Dennis Mitsugu Yasuda
Archive | 1994
Atsushi Akahane; Shintaro Nishimura; Hiromichi Itani; Kieran Durkin
Archive | 2006
Nidhi Arora; Humberto Bartolome Arzeno; Roland Joseph Billedeau; Nolan James Dewdney; Kieran Durkin; Tobias Gabriel; Kristen Lynn Mccaleb; Michael Soth; Dennis Mitsugu Yasuda
Archive | 2004
Joseph Terrence Redwood City Connolly; Kieran Durkin; Keshab Sarma; Jiang Zhu
Archive | 2004
Terrence Joseph Connolly; Kieran Durkin; Keshab Sarma; Jiang Zhu